Home > Balance Sheet > MARKSANS PHARMA

MARKSANS PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹3.66 Cr₹11 Cr₹15 Cr₹14 Cr₹7.26 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of MARKSANS PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of MARKSANS PHARMA is ₹3.66 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹3.66 Cr
Mar2024₹11 Cr
Mar2023₹15 Cr
Mar2022₹14 Cr
Mar2021₹7.26 Cr

How is Deferred Tax Assets / Liabilities of MARKSANS PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹3.66 Cr
-65.52
Mar2024 ₹11 Cr
-30.98
Mar2023 ₹15 Cr
11.78
Mar2022 ₹14 Cr
89.48
Mar2021 ₹7.26 Cr -

Compare Deferred Tax Assets / Liabilities of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹8,155.3 Cr -2.3% -24.2% -17.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,187.0 Cr 0.6% -2.4% -7% Stock Analytics
DIVIS LABORATORIES ₹163,282.0 Cr -0.3% -7.6% 23% Stock Analytics
CIPLA ₹128,619.0 Cr 1.8% 8.1% -0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹124,712.0 Cr 0.9% 3.7% 8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,577.0 Cr 1% 2.4% -9.6% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-2.3%

-24.2%

-17.6%

SENSEX

0.9%

-1.1%

0.6%


You may also like the below Video Courses